All updated as on -
The global thermostats market was worth $3.25 billion in 2022 and is expected to reach $5.18 billion by 2030, expanding at a CAGR (compound annual growth rate) of 9.4 percent between 2023 and 2030. The rise of the sports surgery market can be attributed to a variety of factors, including the rising prevalence of sports-related surgeries, the expanding availability of relevant products, and the rising volume of surgical procedures.
The term "hemostat" is used to describe a surgical agent used to control bleeding. Hemostats aid in reducing the need for blood transfusions and the duration of surgical procedures. In order to achieve hemostasis outside of a hospital and prevent deaths from bleeding, hemostatic drugs are crucial. Hemostats are medical devices used to stop the flow of blood and other fluids by compressing blood arteries. In most cases, they are employed in tandem with other surgical measures to control bleeding. The hemostasis market is growing as a result of the many benefits offered by hemostatic drugs. These include faster wound healing and operative times, improved management of anti-coagulated patients, and shorter recovery times for patients.
Arthritis, osteoporosis, lumbar spinal stenosis (LSS), gastroesophageal reflux disease (GERD), and benign prostatic hyperplasia (BPH) are only few of the common age-related diseases and ailments. To decrease pain and enhance joint function, surgery is frequently required for these conditions. Intraoperative bleeding following knee replacement surgery is more likely in patients with arthritis and osteoporosis due to their weaker bones and fragile blood vessels. Hemostatic drugs are vital in regulating bleeding efficiently to prevent complications like hematoma formation and longer surgical periods.
Allergies and other problems with hemostats typically result from their low quality. Infections caused by low-quality goods prolong the healing process and, in the worst-case scenario, can be fatal. Absorbable gelatin-based sponges have been used to mend torn tendons, although reports have shown that this can lead to excessive fibrosis and a protracted fixation of the tendon. If patients don't trust that hemostats are safe to use, they may be less likely to employ them throughout treatment, thus increasing the need for alternatives.
Increases in orthopedic, gynecological, reconstructive, and cardiac surgeries, as well as increases in various cancer types necessitating surgical procedures, as well as the development of new hemostasis product markets by a large number of key players, all contribute to the expansion of the global hemostats market. The market for flowable hemostats is further helped by the rising prevalence of their use. About 200 million people worldwide suffered from osteoporosis-related fractures in 2019, according to the International Osteoporosis Foundation.
As a result, the hemostats market is expected to expand as the prevalence of orthopedic problems grows and more patients require surgical procedures. The market is expanding in large part because of the growing elderly population. This is because to the growing number of procedures performed on elderly patients due to a rise in the prevalence of preventable diseases. The demand for hemostats was further bolstered by the rising incidence of automobile accidents, which necessitated more surgical procedures.
About 235 million major surgical procedures were conducted worldwide in 2019, citing data from the World Health Organization. The National Cancer Institute estimates that 1,806,590 people will be diagnosed with cancer in the United States year 2020. Therefore, spike in number of operations is predicted to support the growth of the market. In 2020, there were an estimated 15.6 million cosmetic procedures, as reported by the American Society of Plastic Surgeons. Growth opportunities in the hemostats market are likely to be particularly promising throughout the forecast period due to the rising number of products receiving regulatory approval. As a result, the potential of the hemostasis market is expected to grow as the number of surgical procedures using hemostats rises.
Market expansion for hemostats is being fueled by the rising prevalence of conditions requiring their use, such as spinal disorders, cardiovascular diseases, cancer, accidents, and trauma. As a result, there has been a worldwide explosion in the number of surgical operations and medical specialists dedicated to the diagnosis, management, and treatment of disease. Hemostats serve an indispensable purpose in the management of bleeding during surgical procedures. The National Cancer Institute estimates that there will be 1,806,590 new cases of cancer in the United States year 2020. NCBI reports that between 60 and 70 percent of all transfused red blood cells are used in surgical procedures, with bleeding during surgery being one of the most complicated situations that can arise. Several surgeons prefer administering these hemostats products in surgical procedures with less risk factor of losing blood, which has increased the demand for the product in the global market. The fact that hemostats are both inexpensive and relatively infection-safe is further contributing to their popularity. Hence, increase in number of operations is likely to drive the Hemostats Market revenue.
Report Coverage
Global Hemostats research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hemostats report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hemostats competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hemostats market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hemostats market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hemostats market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US), Medtronic Plc, Johnson and Johnson, Hemostatis LLC, Becton Dickinson and Company
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Hemostats market based on the below-mentioned segments:
Global Hemostats Market, By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
Global Hemostats market, By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others
Global Hemostats Market, By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
Global Hemostats market, Regional Analysis
The term "hemostat" is used to describe a surgical agent used to control bleeding. Hemostats aid in reducing the need for blood transfusions and the duration of surgical procedures. In order to achieve hemostasis outside of a hospital and prevent deaths from bleeding, hemostatic drugs are crucial. Hemostats are medical devices used to stop the flow of blood and other fluids by compressing blood arteries. In most cases, they are employed in tandem with other surgical measures to control bleeding. The hemostasis market is growing as a result of the many benefits offered by hemostatic drugs. These include faster wound healing and operative times, improved management of anti-coagulated patients, and shorter recovery times for patients.
Arthritis, osteoporosis, lumbar spinal stenosis (LSS), gastroesophageal reflux disease (GERD), and benign prostatic hyperplasia (BPH) are only few of the common age-related diseases and ailments. To decrease pain and enhance joint function, surgery is frequently required for these conditions. Intraoperative bleeding following knee replacement surgery is more likely in patients with arthritis and osteoporosis due to their weaker bones and fragile blood vessels. Hemostatic drugs are vital in regulating bleeding efficiently to prevent complications like hematoma formation and longer surgical periods.
Allergies and other problems with hemostats typically result from their low quality. Infections caused by low-quality goods prolong the healing process and, in the worst-case scenario, can be fatal. Absorbable gelatin-based sponges have been used to mend torn tendons, although reports have shown that this can lead to excessive fibrosis and a protracted fixation of the tendon. If patients don't trust that hemostats are safe to use, they may be less likely to employ them throughout treatment, thus increasing the need for alternatives.
Increases in orthopedic, gynecological, reconstructive, and cardiac surgeries, as well as increases in various cancer types necessitating surgical procedures, as well as the development of new hemostasis product markets by a large number of key players, all contribute to the expansion of the global hemostats market. The market for flowable hemostats is further helped by the rising prevalence of their use. About 200 million people worldwide suffered from osteoporosis-related fractures in 2019, according to the International Osteoporosis Foundation.
As a result, the hemostats market is expected to expand as the prevalence of orthopedic problems grows and more patients require surgical procedures. The market is expanding in large part because of the growing elderly population. This is because to the growing number of procedures performed on elderly patients due to a rise in the prevalence of preventable diseases. The demand for hemostats was further bolstered by the rising incidence of automobile accidents, which necessitated more surgical procedures.
About 235 million major surgical procedures were conducted worldwide in 2019, citing data from the World Health Organization. The National Cancer Institute estimates that 1,806,590 people will be diagnosed with cancer in the United States year 2020. Therefore, spike in number of operations is predicted to support the growth of the market. In 2020, there were an estimated 15.6 million cosmetic procedures, as reported by the American Society of Plastic Surgeons. Growth opportunities in the hemostats market are likely to be particularly promising throughout the forecast period due to the rising number of products receiving regulatory approval. As a result, the potential of the hemostasis market is expected to grow as the number of surgical procedures using hemostats rises.
Market expansion for hemostats is being fueled by the rising prevalence of conditions requiring their use, such as spinal disorders, cardiovascular diseases, cancer, accidents, and trauma. As a result, there has been a worldwide explosion in the number of surgical operations and medical specialists dedicated to the diagnosis, management, and treatment of disease. Hemostats serve an indispensable purpose in the management of bleeding during surgical procedures. The National Cancer Institute estimates that there will be 1,806,590 new cases of cancer in the United States year 2020. NCBI reports that between 60 and 70 percent of all transfused red blood cells are used in surgical procedures, with bleeding during surgery being one of the most complicated situations that can arise. Several surgeons prefer administering these hemostats products in surgical procedures with less risk factor of losing blood, which has increased the demand for the product in the global market. The fact that hemostats are both inexpensive and relatively infection-safe is further contributing to their popularity. Hence, increase in number of operations is likely to drive the Hemostats Market revenue.
Report Coverage
Global Hemostats research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Hemostats report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Hemostats competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Hemostats market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US), Medtronic Plc, Johnson and Johnson, Hemostatis LLC, Becton Dickinson and Company |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Hemostats Market from 2021 to 2030.
- Market Forecast for Hemostats Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Hemostats competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Hemostats
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Hemostats market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Hemostats market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany), Anika Therapeutics, Inc. (US), Stryker (US), and Integra Lifesciences Corporation(US), Medtronic Plc, Johnson and Johnson, Hemostatis LLC, Becton Dickinson and Company
Primary Target Market
- Market Players of Hemostats
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Hemostats market based on the below-mentioned segments:
Global Hemostats Market, By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
Global Hemostats market, By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others
Global Hemostats Market, By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
Global Hemostats market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive hemostats market market research and competitor analysis for your business to help you develop more profound insights into the hemostats market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the hemostats market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.